4SC AG SMA 200
Was ist das SMA 200 von 4SC AG?
SMA 200 von 4SC AG ist €3 +0.00%
Was ist die Definition von SMA 200?
SMA 200 ist ein durchschnittlicher Aktienkurs der letzten 200 Tage, berechnet als ungewichteter Mittelwert der letzten 200 Schlusskurse.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 von Unternehmen in Health Care Sektor auf XETRA im Vergleich zu 4SC AG
Was macht 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Unternehmen mit sma 200 ähnlich 4SC AG
- Viji Finance hat SMA 200 von ₨3 -10.05%
- Osisko Mining hat SMA 200 von CAD$3 +38.96%
- Restaurant Brands New Zealand hat SMA 200 von AUD$3 +12.56%
- Sumeet Industries hat SMA 200 von ₨3 +4.09%
- Minerva Neurosciences Inc hat SMA 200 von $3 -11.41%
- InflaRx N.V hat SMA 200 von €3 -1.22%
- 4SC AG hat SMA 200 von €3 +0.00%
- DiaMedica Therapeutics hat SMA 200 von $3 +31.94%
- Redishred Capital hat SMA 200 von CAD$3 +4.46%
- Credit Suisse Asset Management Income Fund hat SMA 200 von $3 +2.22%
- China Beststudy Education hat SMA 200 von HKD$3 -16.10%
- Mitsubishi Motors hat SMA 200 von $3 -6.66%
- Widepoint Corp hat SMA 200 von $3 +11.34%